SKB BIO-B(06990)

260.000-4.200-1.59%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

Company Profile
Company Name
SKB BIO-B
Market
SEHK
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://kelun-biotech.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is a China-based company mainly engages in the research and development, production and sales of drugs. The Company is mainly engaged in the research and development, manufacturing and commercialization of innovative drugs in oncology, immunology and other therapeutic fields. The Company's products are antibody-drug conjugates (ADCs) SKB264 and A166. The Company's products are mainly used for the treatment of breast cancer, non-small cell lung cancer, Gastrointestinal cancer and other non tumor diseases.
No filings yet

1D
5D
Day
Week
Month

Loading ...

High

266.000

Open

266.000

Volume%

2.48

Low

247.800

Close

264.200

T/O Rate

0.61%

抱歉，当前请求异常(-1)

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"pagemeta":{"title":"SKB BIO-B(06990),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SKB BIO-B(06990) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SKB BIO-B,06990,SKB BIO-B股票,SKB BIO-B股票老虎,SKB BIO-B股票老虎国际,SKB BIO-B行情,SKB BIO-B股票行情,SKB BIO-B股价,SKB BIO-B股市,SKB BIO-B股票价格,SKB BIO-B股票交易,SKB BIO-B股票购买,SKB BIO-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SKB BIO-B(06990),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SKB BIO-B(06990) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}},"tab":"fillings","symbol":"06990","data":{"stockData":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"SKB BIO-B","latestPrice":260,"timestamp":1742544503037,"preClose":264.2,"halted":0,"volume":798746,"delay":0,"floatShares":131000000,"shares":227000000,"eps":-3.0465836396659767,"marketStatus":"Market Closed","change":-4.2,"latestTime":"03-21 16:08:23","open":266,"high":266,"low":247.8,"amount":206814110,"amplitude":0.068887,"askPrice":260,"askSize":4500,"bidPrice":259.2,"bidSize":700,"shortable":3,"etf":0,"ttmEps":-0.9188838892811045,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1742779800000},"marketStatusCode":7,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":264.2,"openAndCloseTimeList":[[1742520600000,1742529600000],[1742533200000,1742544000000]],"volumeRatio":2.480827263210284,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":null,"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":{"websiteUrl":"http://kelun-biotech.com","stockEarnings":[{"period":"1week","weight":0.0417},{"period":"1month","weight":0.3822},{"period":"3month","weight":0.4558},{"period":"6month","weight":0.4723},{"period":"1year","weight":0.6059},{"period":"ytd","weight":0.5922}],"compareEarnings":[{"period":"1week","weight":-0.0113},{"period":"1month","weight":0.0325},{"period":"3month","weight":0.2013},{"period":"6month","weight":0.2975},{"period":"1year","weight":0.4048},{"period":"ytd","weight":0.1809}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is a China-based company mainly engages in the research and development, production and sales of drugs. The Company is mainly engaged in the research and development, manufacturing and commercialization of innovative drugs in oncology, immunology and other therapeutic fields. The Company's products are antibody-drug conjugates (ADCs) SKB264 and A166. The Company's products are mainly used for the treatment of breast cancer, non-small cell lung cancer, Gastrointestinal cancer and other non tumor diseases.","exchange":"SEHK","name":"SKB BIO-B","nameEN":"SKB BIO-B"},"aProfile":null}}}